Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
BIOVERIS CORP (BIOV) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/26/2007 8-K Quarterly results
06/18/2007 8-K Other Events
05/18/2007 8-K Entry into a Material Definitive Agreement
05/03/2007 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Amended and Restated Stockholders Agreement between Roche Holdings Ltd, Samuel J. Wohlstadter and Nadine Wohlstadter"
04/10/2007 8-K Acquisition/merger/asset purchase announced
Docs: "Agreement and Plan of Merger by and among Roche Holding Ltd, Lili Acquisition Corporation and BioVeris Corporation",
"Vaccines Asset Transfer Agreement between BioVeris Corporation and 32 Mott Street Acquisition I, LLC",
"ECL Asset Transfer Agreement between BioVeris Corporation and 32 Mott Street Acquisition II, LLC",
"ECL License Agreement between BioVeris Corporation and 32 Mott Street Acquisition II, LLC",
"Amendment to BioVeris Termination Protection Program",
"BioVeris Severance Plan",
"Non-Disclosure and Non-Solicitation Agreement between BioVeris Corporation and Samuel J. Wohlstadter",
"Transaction Agreement between Samuel J. Wohlstadter and Roche Holding Ltd",
"Stockholders Agreement between Roche Holdings Ltd, Samuel J. Wohlstadter and Nadine Wohlstadter"
04/04/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "ROCHE TO ACQUIRE BIOVERIS FOR $21.50 PER SHARE"
02/09/2007 8-K Results of Operations and Financial Condition
Docs: "BIOVERIS REPORTS THIRD QUARTER FISCAL 2007 RESULTS"
01/26/2007 8-K Other Events
Docs: "BIOVERIS COMPLETES ADDITIONAL VACCINE LICENSE"
01/08/2007 8-K Other Events
Docs: "ROCHE SENDS PRELIMINARY 2004 PAYMENT TO BIOVERIS FOR CERTAIN OUT-OF-FIELD SALES"
12/27/2006 8-K Other Events
Docs: "BIOVERIS COMPLETES NEW VACCINE LICENSE"
10/13/2006 8-K Entry into a Material Definitive Agreement
06/21/2006 8-K Entry into a Material Definitive Agreement
01/18/2006 8-K Other Events, Financial Statements and Exhibits
Docs: "BIOVERIS COMPLETES AGREEMENT WITH THERACARB, INC."
12/06/2005 8-K Other Events, Financial Statements and Exhibits
Docs: "BIOVERIS COMPLETES NEW LICENSE AGREEMENT WITH THE UNIVERSITY OF MASSACHUSETTS AMHERST"
11/22/2005 8-K Other Events, Financial Statements and Exhibits
Docs: "BIOVERIS COMPLETES AGREEMENT WITH JEWISH GENERAL HOSPITAL"
09/07/2005 8-K Other Events
Docs: "BIOVERIS COMPLETES AGREEMENT WITH THE ROCKEFELLER UNIVERSITY"
07/20/2005 8-K Entry into a Material Definitive Agreement
07/20/2005 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Other Events
Docs: "RICHARD J. MASSEY TO RETIRE FROM BIOVERIS"
07/07/2005 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Commercial Lease Agreement by and between BT-Newyo, LLC and BioVeris Corporation"
05/26/2005 8-K Other Events
Docs: "BIOVERIS COMPLETES AGREEMENTS WITH UNIVERSITY OF MASSACHUSETTS AT AMHERST"
01/13/2005 8-K Other Events
Docs: "BIOVERIS COMPLETES AGREEMENTS WITH CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND"
10/20/2004 8-K Other Events
Docs: "Annual Meeting of Stockholders This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements about business prospects, utility of the Company's technology and products, market opportunities and growth, revenue growth and new business or product plans. Actual results might differ materially from these statements due to risks and uncertainties, including the utility and market acceptance of new products, the impact of competitive products, and enforcement of intellectual property rights. A more detailed description of these and other risks applicable to BioVeris appears in the company's documents filed with the Securities and Exchange Commission and available on request from BioVeris. The company disclaims any intent or obligation to update these forward-looking statements. Forward-Looking Statement Disclaimer"
10/20/2004 8-K Other Events
Docs: "16020 Industrial Drive, Gaithersburg, Maryland 20877 USA Phone: 869-9800, Fax: 208-3798"
10/20/2004 8-K Other Events
Docs: "BIOVERIS EXPANDS BUSINESS MODEL TO TARGET THE FIELDS OF IMMUNOGENICITY, VACCINES AND VACCINATION SERVICES"
09/17/2004 8-K Other Events
Docs: "BIOVERIS COMMON STOCK TO CONTINUE NASDAQ LISTING"
07/20/2004 8-K Other events
Docs: "BIOVERIS RECEIVES NASDAQ DELISTING NOTIFICATION"
07/16/2004 8-K Other events
Docs: "BIOVERIS: SECOND COMPLAINT FILED AGAINST MESO SCALE DIAGNOSTICS"
07/16/2004 8-K Results of Operations and Financial Condition
Docs: "BIOVERIS REPORTS SELECTED UNAUDITED FINANCIAL RESULTS FOR FISCAL YEAR 2004"
06/15/2004 8-K Other events
Docs: "BIOVERIS COMMENCES INVESTIGATION OF MESO SCALE DIAGNOSTICS AND FILES COMPLAINT IN DELAWARE COURT"
05/27/2004 8-K Other events
Docs: "BIOVERIS ADDS TWO NEW MEMBERS TO BOARD OF DIRECTORS"
05/05/2004 8-K Other events
03/11/2004 8-K Changes in registrant's certifying accountant
Docs: "Exhibit 16 March 11, 2004 Securities and Exchange Commission Mail Stop 11-3 450 5th Street, N.W. Washington, D.C. 20549"
02/17/2004 8-K Other events
Docs: "BIOVERIS (NASDAQ: BIOV) SHARES DISTRIBUTED BY IGEN; SHARES EXPECTED TO BEGIN TRADING FEBRUARY 17 BIOVERIS REPORTS 3RD QUARTER FINANCIAL RESULTS"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy